Loading...
Loading...
ISI Group initiated its coverage on Illumina
ILMN with a Market Weight rating and a $45 price target.
ISI Group noted, "We are initiating coverage on shares of Illumina with a Market Weight rating and a price target of $45.00, which on a forward basis equates to ~12x EV/EBITDA and ~25x operating EPS. Our thesis for ILMN is based on our view that strong growth in MiSeq and an improving HiSeq through-put will help to offset an
increasingly challenging budgetary environment, that microarray growth will remain modest as demand for emerging applications helps to soften a slowdown in legacy GWAS, and that recent strategic interest in asset (e.g. Roche's hostile bid) provides a modest valuation premium."
Illumina closed at $40.60 on Monday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in